Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Liver Cirrhosis

Free Subscription 15.12.2025 2 BMC Gastroenterol 1 Clin Res Hepatol Gastroenterol 1 Dig Dis Sci 1 Hepatology 1 Lancet 1 PLoS One 1 Transplant Proc 1 Z Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. NG M, Bardhi O, Lai K, Koo E, et al
   Etiology of cirrhosis is associated with risk of hepatic decompensation and hepatocellular carcinoma.
   BMC Gastroenterol. 2025 Dec 9. doi: 10.1186/s12876-025-04538.
   PubMed         Abstract available
   
   
2. PHUKAN C, Talukdar AJ, Dutta S, Saha S, et al
   Novel urinary biomarkers to differentiate AKI etiologies and predict mortality in decompensated cirrhosis patients: a prospective cohort study.
   BMC Gastroenterol. 2025 Dec 7. doi: 10.1186/s12876-025-04462.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

3. MARTINEZ-SANCHEZ FD, Agurre-Villarreal D, Argaiz ER, Rosales-Renteria LA, et al
   Physiology-Guided Albumin Therapy in Decompensated Cirrhosis: The Expanding Role of Point-of-Care Ultrasound.
   Clin Res Hepatol Gastroenterol. 2025 Dec 9:102744.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

4. ZHANG J, Ren Y
   Lean MASLD Cirrhosis and Mortality: Considerations for Liver Transplant Candidate Evaluation.
   Dig Dis Sci. 2025 Dec 11. doi: 10.1007/s10620-025-09601.
   PubMed        
   
   

   
   Hepatology

5. JI J, Chen Z, He W, Chen Y, et al
   CXCR6 defines a distinct resident state in gammadelta T cells for protecting from liver cirrhosis.
   Hepatology. 2025 Dec 11. doi: 10.1097/HEP.0000000000001643.
   PubMed         Abstract available
   
   

   
   Lancet

6. NOUREDDIN M, Harrison SA, Loomba R, Alkhouri N, et al
   Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study.
   Lancet. 2025 Nov 11:S0140-6736(25)02114-2. doi: 10.1016/S0140-6736(25)02114.
   PubMed         Abstract available
   
   

   
   PLoS One

7. HORI T, Aihara KI, Kawano Y, Watanabe T, et al
   Fibrosis-4 and 3 indices are independently associated with annual hemoglobin decline in individuals with metabolic disorders: A hospital-based retrospective cohort study.
   PLoS One. 2025;20:e0338372.
   PubMed         Abstract available
   
   

   
   Transplant Proc

8. CHENG SM, Weng LC, Lee WC, Chen LT, et al
   The Correlation of Hemodynamic Changes and Early Allograft Function Following Liver Transplantation.
   Transplant Proc. 2025 Oct 31:S0041-1345(25)00543.
   PubMed         Abstract available
   
   

   
   Z Gastroenterol

9. STEIN K, Hofmann WP, Franke A, Petroff D, et al
   Clinical characteristics of newly diagnosed patients with primary biliary cholangitis (PBC) indicate the need for better awareness on timely diagnosis and adequate UDCA therapy.
   Z Gastroenterol. 2025;63:1260-1267.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.